Top Markets
Coin of the day
Molecular Pharmacology (USA), Ltd. Molecular Pharmacology (USA), Ltd.

Molecular Pharmacology (USA), Ltd.

MLPH
Rank in Stocks #39112
As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is... As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is dedicated to the creation and market introduction of solutions for pain and inflammation, with a primary focus on the Australian and United States markets. Through its subsidiary, Molecular Pharmacology Pty. Ltd., it is advancing an analgesic and anti-inflammatory molecule called Tripeptofen, designed to alleviate common daily pain. These products are offered in diverse dosage forms, formulations, and packaging options to suit various needs. MLPH's marketing strategy involves leveraging pharmaceutical distributors and forging collaborative partnerships with companies in the United States and Europe. Additionally, the company maintains an agreement with Dermatology Development Corporation to jointly develop and market a suite of therapeutic, cosmetic, and cosmeceutical items derived from the ThermaLIFE product line and its core active component. Headquartered in Perth, Australia, Molecular Pharmacology (USA) Limited operates as a subsidiary of PharmaNet Group Limited.
Share Price
$0.0322
Last synced: 2026-08-11
Market Cap
$643.71K
Change (1 day)
0.00%
Change (1 year)
544.00%
Country
AU
Trade Molecular Pharmacology (USA), Ltd. (MLPH)

Category

Stock price history for Molecular Pharmacology (USA), Ltd. (MLPH)
Highest end of day price: $0.03 on 2026-08-01

Lowest end of day price: $0.47 on 2009-07-01
Stock price history of Molecular Pharmacology (USA), Ltd. from 2009 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 57.97%
2025 300.00%
2024 -86.58%
2023 27.20%
2022 485.71%
2021 -95.90%
2020 31.25%
2019 -32.31%
2018 100.97%
2017 14.79%
2016 -83.06%
2015 -16.84%
2014 -47.72%
2013 50.34%
2012 720.91%
2011 -87.47%
2010 -59.86%
2009 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$517.18 32.51%
US
$857.76 31.47%
NL
$728.31 6.63%
CH
$1.07K -6.40%
KR
$254.43 12.40%
BE